Literature DB >> 6635322

Reduced plasma kininogen concentration during sickle cell crisis.

P S Verma, R G Adams, R L Miller.   

Abstract

Eight patients with sickle cell anemia (SS hemoglobin) were found to have decreased plasma levels of kininogen compared to normal control subjects. The kininogen level of the patients with sickle cell anemia was decreased further during sickle cell crises. The results suggest that components of the kinin system are profoundly affected in patients with sickle cell anemia, and during crises may play a role in the clinical presentation of patients.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6635322

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


  7 in total

1.  Red blood cells and thrombin generation in sickle cell disease.

Authors:  Matthew F Whelihan; Ming Y Lim; Nigel S Key
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

2.  High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease.

Authors:  Erica M Sparkenbaugh; Malgorzata Kasztan; Michael W Henderson; Patrick Ellsworth; Parker Ross Davis; Kathryn J Wilson; Brandi Reeves; Nigel S Key; Sidney Strickland; Keith McCrae; David M Pollock; Rafal Pawlinski
Journal:  J Thromb Haemost       Date:  2020-08-27       Impact factor: 5.824

Review 3.  Sickle cell disease: an inherited thrombophilia.

Authors:  Ted Wun; Ann Brunson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 4.  Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.

Authors:  Zahra Pakbaz; Ted Wun
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 5.  How I diagnose and treat venous thromboembolism in sickle cell disease.

Authors:  Arun S Shet; Ted Wun
Journal:  Blood       Date:  2018-05-15       Impact factor: 22.113

Review 6.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

Review 7.  Linking Labile Heme with Thrombosis.

Authors:  Marie-Thérèse Hopp; Diana Imhof
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.